These policies limit export opportunities for U.S. companies, increase the burden on the United States to finance global drug development, and reduce the flow of investment into new treatments and cures.
Senator Young addresses the impact of foreign pricing policies.
Share
More from Todd Young
I am leading a bipartisan coalition in Congress that clearly sees the grave risks to our people and economy.
There aren’t many issues like this. In a divided America, this could unify America.
Today, roughly 200 members of Congress own shares in publicly traded companies.
Other voices in this conversation
